Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erythropoietin receptors on cancer cells: a still open question.

Literature DB >> 17470877

Erythropoietin receptors on cancer cells: a still open question.

Fulvio Della Ragione, Valeria Cucciolla, Adriana Borriello, Adriana Oliva, Silverio Perrotta.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2007 PMID： 17470877 DOI： 10.1200/JCO.2006.09.7212

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

Authors: Silverio Perrotta; Valeria Cucciolla; Marcella Ferraro; Luisa Ronzoni; Annunziata Tramontano; Francesca Rossi; Anna Chiara Scudieri; Adriana Borriello; Domenico Roberti; Bruno Nobili; Maria Domenica Cappellini; Adriana Oliva; Giovanni Amendola; Anna Rita Migliaccio; Patrizia Mancuso; Ines Martin-Padura; Francesco Bertolini; Donghoon Yoon; Josef T Prchal; Fulvio Della Ragione
Journal: PLoS One Date: 2010-08-05 Impact factor: 3.240

2. Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.

Authors: Ke Liang; Songbo Qiu; Yang Lu; Zhen Fan
Journal: Cancer Biol Ther Date: 2013-10-22 Impact factor: 4.742

7. The endogenous erythropoietin in correlation with other erythrocytic parameters in patients with head and neck squamous cell carcinoma treated with platinum-based induction chemotherapy.

Authors: Dominika Leś; Maria Saduś-Wojciechowska; Tomasz Rutkowski; Andrzej Wygoda; Krzysztof Składowski
Journal: Contemp Oncol (Pozn) Date: 2019-10-31

7 in total

Erythropoietin receptors on cancer cells: a still open question.

1. EPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursors.

2. Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells.

3. The effect of erythropoietin on normal and neoplastic cells.

4. Erythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cells.

5. Recombinant human epoetin beta in the treatment of chemotherapy-related anemia.

6. Epo receptors are not detectable in primary human tumor tissue samples.

7. The endogenous erythropoietin in correlation with other erythrocytic parameters in patients with head and neck squamous cell carcinoma treated with platinum-based induction chemotherapy.